| |
||||||
|
Clinical efficacy is generally demonstrated through a three step process.
The Federal Trade Commission (FTC) regulates OTC product claims. Generally, a product must show efficacy in two separate clinical trials before it may be advertised as “clinically proven”. As noted, “clinically proven” products are the exception in the OTC marketplace, and have a history of performing extremely well. The value of clinical trials cannot be overstated. At PuraMed BioScience, we pride ourselves on ensuring
that all of our products have clinical evidence to support their efficacy
and are manufactured under strict manufacturing protocols.
A clinical trial by a well known institution can generate a tremendous amount of free publicity for the Company. The awareness and credibility associated with the release of favorable clinical results can propel product into retail outlets with speed and without many of the costs (slotting fees, etc.) normally planned for. Lower product liability rates are another benefit of performing clinical trials. Provided the presently ongoing clinical trials generate favorable results, of which the Company is highly confident, the Company will become immediately well known, along with its migraine product.
Check back for updates soon. |
|||||
|
||||||